Question Bank › Promise already turning into fact

Promise already turning into fact

Promise already turning into fact: management shows the thing it told investors was coming is now measurably arriving, a

Calls Tested
309
Answered YES
46
Hit Rate
14.9%
rare by design

Emerson Electric Co. (EMR) — this company's answers

NO on the Q3 2021 call 2021-08-04 B+
The model's full reasoning — Q3 2021 call → NO我们根据提供的财报电话会议记录来判断。问题问的是管理层是否指出了之前告诉投资者会发生的增长性发展,并且现在有实际活动证明它正在实现,同时管理层表示这还处于早期阶段。 在记录中,管理层提到了几个增长性发展。例如,Lal Karsanbhai 在开头提到“我们的OSI收购表现非常好,超出了我们的内部协同计划”。但这是关于收购的表现,不是之前承诺的增长发展。更相关的是关于“成本重置计划”的讨论,但那是成本削减,不是增长。 关键部分:在回答关于自动化解决方案增长的问题时,Lal 说:“我认为这是公平的。看,复苏主要是由现代化和MRO支出推动的……我预计这两个业务部门的转化……会继续。”这似乎是在回应分析师关于中期增长率的假设,但并没有明确提到之前设定的预期。 另一个可能:在讨论“脱碳机会”时,Lal 提到“我们确定了新的脱碳机会……这些机会价值4亿美元,约120个项目。”但这是新信息,没有提到之前告诉投资者会来。 在回答关于商业住宅业务的问题时,Lal 说:“我们正在密切关注住宅空调周期……但就目前而言,我预计随着秋季的到来,订单会有所减弱。”这似乎是在说预期会减弱,而不是增长。 在回答关于自动化解决方案订单的问题时,Lal 说:“我们继续看到自动化解决方案的势头增强。”但这是当前情况,没有提到之前预期。 最接近的是关于“成本重置计划”的讨论,但那是成本,不是增长。 也许关于“OSI”的讨论:Lal 说:“OSI的整合进展非常顺利。我们对收购和迄今为止的结果非常满意,并且对协同计划越来越有信心。”但这是关于收购的,不是之前承诺的增长发展。 在回答关于2022年增长的问题时,Lal 说:“我相信会增长。而且我们将在……看到的是整个业务的积压订单达到11亿美元。这就是推动有机增长的动力。”但这是当前积压,不是之前预期。 没有明确提到“我们之前说过这个会来”之类的。 因此,似乎没有符合三部分模式的内容。管理层没有明确指回之前设定的增长预期并确认其正在实现且仍处于早期。 所以答案应为NO。

← Back to the full EMR analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management point to a growth-bearing development in its business that IT HAD PREVIOUSLY TOLD INVESTORS TO EXPECT — and demonstrate, with real current-period activity, that this development is NOW ACTUALLY ARRIVING at or beyond the pace management had indicated, while ALSO conveying that the development is still early, with most of its contribution ahead? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent three-part pattern: (1) A PRIOR EXPECTATION MANAGEMENT ITSELF HAD SET. Management refers back — explicitly or in plain substance — to something about the growth of the business it had previously communicated or anticipated: a ramp, launch, recovery, adoption, expansion, capacity fill, customer conversion, or similar forward development it told investors was coming. The reference may be phrased in many ways ('as we said last quarter...', 'consistent with what we laid out...', 'we told you this would begin...', 'in line with the plan we described...'), so long as it concerns the business growing or inflecting — not a cost program, financing step, or routine housekeeping. (2) CURRENT REALITY IS NOW CONFIRMING IT. Management points to concrete activity in the just-reported period or happening now — actual orders, customers, volumes, shipments, deployments, utilization, openings, sign-ups, revenue from the new thing, or equivalent real events — as evidence that the anticipated development is materializing on schedule or faster/bigger than indicated. The confirmation must rest on things that already happened, described with enough substance that the arrival is observable rather than asserted. (3) MANAGEMENT SAYS IT IS STILL EARLY. Management conveys, directly or plainly in substance, that what has arrived so far is only the beginning of the development — the ramp is in its early innings, contribution to reported results is still small relative to what the same trajectory delivers ahead, further stages are already scheduled or in motion — so the reported numbers understate where the confirmed trajectory is already heading. The essence is ONE phenomenon: a management team that made a growth claim, is now standing in front of evidence that the claim is coming true, and is telling investors the verified trajectory has much further to run. The industry, the nature of the development, and the form of the evidence may vary widely. Answer NO if management describes promising developments with no indication it had previously set that expectation — a fresh announcement is not verification. NO if the look-back is only to beating financial guidance or consensus numbers, with no underlying operating development being confirmed. NO if the previously-promised item is a cost reduction, restructuring, refinancing, or housekeeping matter rather than a growth-bearing development. NO if the confirmation rests on pipeline, interest, letters of intent, or expectations rather than real current activity. NO if management indicates the development is now substantially complete or fully reflected in results, with little still ahead. NO if management is explaining that the anticipated development is late, smaller than expected, or being walked back. NO if the pattern appears only in an analyst's question or summary that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
MCD McDonald's Corporation Q2 2024 2024-07-29 D
AES The AES Corporation Q1 2024 2024-05-03 C+
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
SITM SiTime Corporation Q2 2023 2023-08-02 C+
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
XHR Xenia Hotels & Resorts, Inc. Q2 2022 2022-08-05 A
BRKL Brookline Bancorp, Inc. Q2 2022 2022-07-30 B+
UPWK Upwork Inc. Q2 2022 2022-07-27 C+
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
EXP Eagle Materials Inc. Q3 2022 2022-01-27 B
WES Western Midstream Partners, LP Q3 2018 2018-10-31 D
MAS Masco Corporation Q3 2018 2018-10-30 C
AU AngloGold Ashanti's Q2 2018 2018-08-20 B
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
INST Instructure's Q4 2017 2018-02-12 B+
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
GNTX Gentex Corporation Q3 2017 2017-10-20 B
MXL MaxLinear, Inc. Q2 2017 2017-08-08 C+
BIIB Biogen Inc. Q2 2017 2017-07-25 B
CNS Cohen & Steers, Inc. Q2 2017 2017-07-20 B
PTC PTC Inc. Q3 2017 2017-07-19 C+
PLAB Photronics, Inc. Q2 2017 2017-05-17 C+
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
ICFI ICF International, Inc. Q1 2017 2017-05-06 B+
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C
MDLZ Mondelez International, Inc. Q4 2016 2017-02-07 C
BP BP p.l.c. Q4 2016 2017-02-07 B+
NTCT NetScout Systems, Inc. Q2 2017 2016-10-27 D
F Ford Motor Company Q3 2016 2016-10-27 B+
MAT Mattel, Inc. Q3 2016 2016-10-19 C
NDSN Nordson Corporation Q3 2016 2016-08-23 A
VRNS Varonis Systems, Inc. Q2 2016 2016-08-09 B+
NWSA News Corporation Q2 2016 2016-08-08 C+
CGNX Cognex Corporation Q2 2016 2016-08-01 A
TRV The Travelers Companies, Inc. Q2 2016 2016-07-21 C+
LBTYK Liberty Global's Q1 2016 2016-05-10 C+
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
HD The Home Depot, Inc. Q4 2015 2016-02-23 A
SAN Banco Santander, S.A. Q4 2015 2016-01-27 B
HXL Hexcel Corporation Q4 2015 2016-01-22 B+

How the model reasoned

ICFI · Q1 2017 → YESThe question is: Does management point to a growth-bearing development that they previously told investors to expect, and now it's arriving with current activity, but still early with most contributio...YES Management explicitly references the themes from their February 2017 full-year earnings call (only two months prior), noting that the January-February pickup they had highlighted there continued through March. They then point to concrete current-period activity: ICF Olson won over $75 million in new revenue since acquisition (neither firm could have won independently), added substantial new-account wins in Q1, and saw its qualified pipeline rise significantly above year-end 2016 levels. John Wasson confirms the new projects and retainers are now lining up, with strong Q1 wins and momentum from added staff. Sudhakar states they expect mid-single-digit growth this 2017 and sequential improvement, while reiterating confidence in the medium-term outlook. The language makes clear the ramp is still early—H2 comparisons and most of the contribution lie ahead—matching the three-part pattern for this growth-bearing development. No other item in the call satisfies all three criteria as cleanly.
HOLX · Q4 2017 → YESThe question is about whether management points to a growth-bearing development they previously told investors to expect, and now it's arriving with current activity, but still early. YES The transcript shows a clear three-part pattern for international growth. Management explicitly references its prior expectation: “while we thought that international would be a double-digit grower by 2018, we've actually delivered on that promise a year earlier than anticipated.” In the just-reported Q4, they confirm the development with concrete activity 17.5% international growth (excluding Cynosure and blood), the sixth consecutive quarter of double-digit growth for molecular internationally, and Panther shipments exceeding prior-year levels. They also state it is still early with most contribution ahead: “we've actually delivered on that promise a year earlier,” and they hope investors remember this 2017 success story as they evaluate Cynosure 2.
PTC · Q3 2017 → YESThe question is about whether management points to a growth-bearing development they previously told investors to expect, and now it's arriving with current activity, but still early. YES Management explicitly references its prior long-term growth ambition for IoT (30-40% bookings growth, consistent with the faster-growing IoT market) as part of its double-digit overall plan, which it had communicated as the target to achieve sustainable growth. In the current quarter, it confirms this is materializing with 40%+ of IoT bookings from customer expansions, six-figure deals growing sequentially and year-over-year, and specific closed expansions with leading food/beverage, aerospace/defense, and medical device companies, plus strong contribution from these. It further conveys the development remains early by noting customers are "generally still in the early days of their IoT journeys" with "adoption is gaining momentum" and "further stages" (e.g.

More from the question bank

Customers coming back on their ownEscape velocity out of a small baseCounterparties stepping up before the numberFresh evidence outrunning the reported numbeCash cost of the waitSequential re-ratingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.